Availability and use of hemostatic agents in prehospital trauma patients in Pennsylvania translation from the military to the civilian setting.

OBJECTIVE: To understand the translation of one innovation in trauma care from the military to the civilian setting, the adoption of topical hemostatic agents in the Emergency Medical Services (EMS) community and in Trauma Centers in Pennsylvania.
METHOD: We utilized an anonymous electronic survey of EMS Agency Administrative Officers and Trauma Center Coordinators.
RESULTS: We received responses from 23% (93/402) Advanced Life Support and Air Medical agencies in the State. Of the EMS agencies that responded, 46.6% (61/131) stock hemostatic products, with 55.5% (44/79) carrying QuickClot® Combat Gauze®. Of the agencies that carried hemostatic products, 50% utilized them at least once in the prior 6 months and 59% over the past 12 months. Despite the infrequent number of applications, prehospital providers ranked themselves as somewhat skilled and comfortable both with the application of the products and the indications for their use.
CONCLUSION: Our survey found that 46.6% of the respondents indicated they carry hemostatic products, a much greater number than found on prior surveys of EMS agencies. There is a steady acceptance by EMS of new innovations in trauma care although more work is needed in translating the exact role of hemostatic agents in the civilian setting.

Introduction

Clinical knowledge, especially regarding care of the trauma patient, has often flowed between the civilian and military settings. The past decade’s experience of combat care in Operation Enduring Freedom (Afghanistan) and in Operation Iraqi Freedom (Iraq) has seen a dramatic increase in the knowledge flow from the battlefield to the civilian setting. Tactical Combat Casualty Care has drastically changed the practice of combat medicine by training front-line personnel in advanced life-threatening treatments, including hemorrhage control.1,2 Early and frequent use of tourniquets and hemostatic agents are examples of innovations adopted by front-line troops and medics in controlling early hemorrhage.1,2 The US Military deployed first- and second-generation hemostatic dressings to combat troops in Iraq and Afghanistan after extensive investment in translational research. The type of agent deployed changed frequently during the ongoing operations from biologic agents containing blood products to chitin-based and then mineral-based products. Military researchers and manufacturers were able to fast-track development and United States Food and Drug Administration approval as many of the products were considered medical devices.3

The percent of combat casualties surviving from wounds suffered during combat in Iraq and Afghanistan was 90%, an unprecedented level compared with casualties from Vietnam (84%) and World War II (80%). However, acute hemorrhage remains the leading cause of combat death.4 Hemostatic products were initially chosen based on animal model studies and revised after real-world combat experience. The initial studies were designed to test the safety and efficacy of the products. Adoption of early agents was based on studies with animal models and subsequent case reports have confirmed their utility under combat conditions.5

The American College of Surgeons (ACS) Committee on Trauma released an evidence-based guideline on the use of hemostatic agents. The ACS recommended that topical hemostatic agents be used “in combination with direct pressure, for the control of significant hemorrhage in the prehospital setting in anatomic areas where tourniquets cannot be applied and where sustained direct pressure alone is ineffective or impractical.” The agents should be “delivered in a gauze format that supports wound packing.”6 The recommendations were based on both prehospital studies in the military and civilian setting as well as animal studies. As there was a paucity of human studies, the strength of this recommendation was categorized as “low” and the quality of evidence as “weak”.

In this study, we aimed to understand the translation of one innovation in trauma care from the military to the civilian setting, the adoption of topical hemostatic agents in the Emergency Medical Services (EMS) community on a statewide level. Our hypothesis is that the majority of civilian EMS agencies in Pennsylvania have adopted hemostatic agents in the care of trauma patients.

Methods

We surveyed all EMS agencies in the Commonwealth of Pennsylvania utilizing contact information from the Pennsylvania Emergency Health Services Council, an independent advisory body to the Pennsylvania Department of Health.7 We also surveyed accredited Pennsylvania Trauma Centers utilizing contact information from the Pennsylvania Trauma Systems Foundation, the accrediting body for trauma centers throughout the Commonwealth of Pennsylvania.8 We sent one survey to the Administration Officer of each licensed EMS agency and one to the Trauma Coordinator of each designated Trauma Center (levels I–IV). We used Survey Monkey (Palo Alto, CA, USA) to conduct the inquiries in an anonymous manner (Table 1). We used a 1–7 Likert-type scale to understand the respondents’ skill in using hemostatic products and their comfort in the indications for their use, with 1 being least skilled or comfortable and 7 being extremely skilled or comfortable. The survey was conducted from April 15, 2016 to May 30, 2016.

Table 1

Questionnaire for Emergency Medical Services (EMS) and Trauma Centers

Questions for EMS agencies	Questions for Trauma Centers
In which regional council are you located?	In which county are you located?
What is the highest level of service for which the agency is licensed?	What is the Hospital’s Trauma Level designation?
Does the agency stock hemostatic products? Which impregnated gauze product is your agency trained and authorized to carry?	Does the Trauma Center carry hemostatic products? Which impregnated gauze products are stocked by the facility?
How often has your EMS agency used hemostatic products over the last 6 months? Over the past 12 months?	How often has the facility received patients with hemostatic agents applied prehospital over the past 6 months? Over the past 12 months?
How many training hours on the use of hemostatic products has your	How often has the trauma team used hemostatic agents in the Trauma
EMS agency provided over the past 12 months?	Bay over the past 6 months? Over the past 12 months?
Rate the skill and comfort levels of the practitioners in your EMS agency regarding the indications for and utilization of hemostatic agents	Rate the skill and comfort level of trauma team in utilizing hemostatic agents

The Reading Health System Institutional Review Board (IRB) reviewed the study and determined it met the requirement for exemption from IRB review found in the Code of Federal Regulations, Title 45, Part 46, Section 101(b)(2). This determination was based on the following: the research is found to be of minimal risk, the research involves the use of survey procedures in which the information obtained is not recorded in such a manner that human subjects can be identified, and any disclosure of the subjects’ responses outside the research will not reasonably place them at risk of criminal or civil liability or be damaging to their financial standing, employability or reputation. Informed consent to participate was obtained with the first question of the survey. If participants did not want to respond to the survey, the questions ended.

Results

EMS agencies

The responding agencies represented nearly every region of the state including urban, suburban, and rural environments. Respondents represented 12 of the 14 Regional EMS Councils. We received responses from 23% (89/387) of all Advanced Life Support agencies in the state and 26.6% (4/15) of Air Medical units. Only 3.87% (39/1007) of the Basic Life Support/Quick Response Service agencies responded to the survey. Ten respondents did not indicate their level of service. Fifty-three percent of those who responded to question 3 (70/131 with 11 not answering) indicated that they did not carry any hemostatic agent; but of those agencies that did stock hemostatic agents, the majority used QuikClot® Combat Gauze® (Figure 1) with 14 agencies carrying more than one product.

Figure 1

Which of the following impregnated gauze products does your agency or Trauma Center carry?

Abbreviation: EMS, Emergency Medical Services.

Of the 61 respondents who indicated they carry hemostatic agents, 59% (36/61) used them at least once in the prior 6 months and 68.85% (42/61) at least once over the past 12 months of the survey (Figure 2). Although 61 agencies carry hemostatic product, 84 agencies indicated that they have provided at least 1 hour of education on their use.

Figure 2

How often has your EMS agency used hemostatic products?

Abbreviations: NA, not applicable; EMS, Emergency Medical Services.

Using a Likert-type scale of 1–7, EMS providers scored a median of 4.0 (interquartile range [IQR] of 2–6) on skill in the application of hemostatic products and a median of 4 (IQR of 3–6) in rating their comfort level in the indications for using hemostatic products. The scores indicated that the majority of respondents scored themselves at or greater than just somewhat skilled and comfortable in using hemostatic products.

Trauma Centers

Twenty-two of the 36 (61.1%) designated Trauma Centers responded to the survey with a broad distribution throughout the counties. The majority of the respondents were level I designated (6) and level II designated (5) with eight centers not answering the question. Although half of the respondents did not answer which hemostatic agents were stocked by their facility, for those that carried any agents, most carried QuikClot Combat Gauze (Figure 1). Two hospitals carried more than one product.

Trauma Centers indicated that EMS infrequently transported patients with hemostatic product applied in the pre-hospital setting. Three centers had received only one patient in the prior 6 months and one had received 2–5 patients in the prior 6 months. Four of these centers received 2–5 patients and one center received >10 patients in the preceding 12 months. Nine Trauma Centers indicated that they had never received patients with prehospital applied hemostatic product over the past 12 months with eight centers not answering the question.

The primary application of these products in the Emergency Department by the Trauma team was also infrequent. Over the prior 6 months, two centers had each applied the agents once and five had each applied the product two to five times. Over the past 12 months, three centers each had applied the products 2–5 times, three had each applied the products 6–10 times, and two had each applied the products >10 times. Compared to EMS providers, Trauma Centers scored a median of 6.0 (IQR 1–7) in application skills and a median of 6.0 (IQR 1–7) in comfort in the indications for using hemostatic agent based on a Likert-type scale of 1–7. Trauma Centers scored EMS providers with a median of 4 (IQR 1–6) for skill and a median of 4 (IQR 1–6) in comfort with indication for hemostatic agents.

Discussion

Many of the initial studies on hemostatic agents consisted of laboratory studies and animal models. The recent combat in Iraq and Afghanistan provided retrospective observational studies on their utility in combat environments.3,9 The literature has few studies indicating how best to translate the experience of these agents to the civilian world. Galante et al surveyed 31 EMS agencies in California and found that only 7% of respondents currently deployed hemostatic agents with questions regarding their benefit in the civilian setting, complications with use, and cost being the most widely cited barriers to increased utilization.10 Agencies were more likely to deploy and utilize tourniquets than hemostatic agents. Among law enforcement personnel, 34% and 29.8% of respondents in a nationwide survey by Aberle et al reported their departments issuing tourniquets and hemostatic agents, respectively.11 As expected, agencies deploying these products also were more likely to conduct training on their use.11

The Israeli Defense Force also had success in incorporating these agents in the care of combat casualties.12 There have been only a few studies reviewing the use of hemostatic agents in the civilian setting. The prior studies conducted under austere combat conditions may not translate to the civilian setting. These conditions include needing to care for patients during combat, delay in evacuation to a treatment facility, and first treatment facility not being a tertiary facil ity.13 Brown et al conducted a retrospective chart review on 37 uses in a civilian setting by EMS providers after receiving training on the product and its deployment.14 They noted that an overall success rate in controlling bleeding was 79%. This study had a small number of patients and the authors note that the infrequency of application may play a role in maintaining prehospital provider proficiency. The study also used a Hem Con dressing. Recently, the Tactical Combat Casualty Care Guidelines have recommended using Combat Gauze as a first-line agent to control significant bleeding.14,15 Hatamabadi et al performed a prospective randomized trial of traditional direct pressure versus a Celox-coated gauze in managing bleeding in civilian stab wounds.16 Their results demonstrated that hemostasis was achieved earlier and blood loss was significantly less with the use of a hemostatic agent.16 The literature has few studies indicating how best to translate the experience of these agents to the civilian world. The few studies that do exist utilized agents no longer recommended by the Committee on Tactical Combat Casualty Care.17 On the basis of recent studies by te Grotenhuis et al and Leonard et al, hemostatic agents seem to be efficacious in adjunctive control of bleeding in the prehospital civilian setting. The total number of applications of hemostatic gauze in both studies was small, however.18,19

Zietlow et al reported on their experience with hemostatic agents and tourniquet use in a single rural ground and rotor-wing medical transport service. Out of 203,301 ground ambulance and 8,987 air transport records, 73 patients were treated with 77 tourniquets and 62 hemostatic dressings were applied to 52 patients, with 7 patients requiring both interventions. The number of patients treated with either or both modalities was 125, which constitutes ~0.06% of all transport records in that period. Hemostatic dressings were only applied when ordinary dressing was unsuccessful in arresting hemorrhage according to their protocol. The success rate of hemostatic dressings in stopping hemorrhage was 95% in this cohort. The authors specifically mentioned that hemostatic dressings would be useful in hemodialysis patients with fistula bleeding. In their units, the 2-year proficiency rate was 98%.20

Our study showed that a substantial proportion of Pennsylvania EMS agencies (46.56% of respondents) had added hemostatic agents to their hemorrhage control armamentarium when compared with a recent survey of EMS agencies.10 A similar percentage of Trauma Centers are currently stocking the agents but less than half of the respondents have utilized the agents at least once over the past 12 months. Although half the EMS agencies that carry the products have used them over the past year, the actual number of applications is small when compared with Pennsylvania statewide 2013 statistics on motor vehicle injuries (10,399), self-inflicted injuries (9,172), and injuries from assault (4,341) or all injuries requiring hospitalizations (132,614).21 The low utilization mirrors the experience in the tri-state area of Iowa, Minnesota, and Wisconsin.20

There is only a small discrepancy between EMS providers, self-reported skill level and comfort with the indications for the use of hemostatic agents and Trauma Center evaluation of prehospital care. On the basis of Galante et al’s findings, we assume that most of the EMS agencies conducting training on the agents are those that have decided to stock them for use. Some agencies are providing many more hours than others, and this may reflect their real-world experience.10 Galante et al also pointed out that although only 7% of respondents in their study were using hemostatic agents, 39% felt that there was a role in civilian EMS agencies.

This study showed that although EMS units are proficient in the use of hemostatic agents, the rate of usage is still low. Although Zietlow et al evaluated the two dominant prehospital units in a tri-state rural setting, our study aimed to provide insight into the availability, self-perception of proficiency among EMS providers, and extent of the use of these agents in a state with multiple EMS agencies.20 Our findings are likely limited by reporting bias, as <30% of all Advanced Life Support and Air Medical units responded. Out of those who reported, only 47% stocked hemostatic agents. This might suggest that although there is increasing acceptance of these agents in the prehospital setting, educational efforts might still be important in promoting usage and familiarity about these agents.

Recently the Committee for Tactical Emergency Casualty Care and the Hartford Consensus IV (HC IV) have provided the framework for translating knowledge obtained from combat care to the civilian setting, especially in high threat scenarios. Central to the vision of the HC IV is educating the lay public to act as immediate responders in arresting hemorrhage until trained professionals arrive. It is envisioned that immediate responders be familiar with hemorrhage control equipment, such as tourniquets and hemostatic dressings. As our survey found that less than half of responding professional EMS agencies in a mature statewide trauma system stock hemostatic dressings, it is important to address this finding if these agents are going to be widely available to the lay public.22,23

Conclusion

There is a lag in translating the military experience with hemostatic dressings to the civilian setting. It is not clear whether the low utilization rates are due to lack of clinical indications for the agents, lack of availability in the EMS Agencies, or lack of comfort with using the product. Future research is needed in the civilian environment to develop training programs and to describe the appropriate role of hemostatic agents with other adjuvants of hemostatic control: elevation, direct pressure, and tourniquets. Addressing any impediments to use in the professional EMS community will be important prior to meeting the HC goals of training immediate responders.